US health panel recommends easing restrictions on controversial peptides
A federal health advisory panel has recommended easing FDA restrictions on several controversial peptides, despite warnings from government scientists regarding safety and efficacy. The move is expected to be supported by health secretary Robert F. Kennedy Jr., potentially leading to increased marketing of these substances for wellness and cosmetic use.
The panel voted 8-6 in favor of putting the peptides on FDA’s list of substances considered safe for pharmacy compounding. The panel voted 8-6 in favor of putting the peptides on FDA’s list of substances considered safe for pharmacy compounding. Trump administration US health panel recommends easing restrictions on controversial peptides Vote from advisory group – whose members include people linked to peptides industry – likely to embolden RFK Jr
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in